Mastectomies For BRCA Ovarian Cancer Survivors Likely Not Effective
Results of the study
The results of the study suggest that prophylactic mastectomy may not be the ideal treatment option for a large percentage of ovarian cancer survivors with BRCA gene mutations. “There is no right or wrong answer on how to manage breast cancer risk in this unique population. However, we hope that our findings provide guidance to women and their doctors deciding if and when prophylactic mastectomy is beneficial following ovarian cancer treatment,” said Rachel Greenup, senior author of the study and assistant professor of surgery at Duke University.
